Full Length Research Paper
References
|
Abd El-Baky RM, Abd El-Azeim NH, Gad GFM (2013). Prevalence of Extended-Spectrum Beta-Lactamase, AmpC Beta- Lactamase, and Metallo-Beta-Lactamase among Clinical Isolates of Pseudomonas aeruginosa. J. Adv. Biotechnol. BioEng. 1:22-29. |
|
|
Aktas Z, Kayacan, CB (2008). Investigation of metallo- β-lactamase producing strains of Pseudomonas aeruginosa and Acinetobacter baumanni by E-test, disk synergy, and PCR. Scand. J. Infect. Dis. 40:320-325. |
|
|
Albertini MT (2002). Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum beta lactamase (ESBLE) in Northern France: a five-year multicentre incidence study. J. Hosp. Infect. 52(2):107-113. |
|
|
Altun S, Tufan ZK, YaÄŸcı S, Önde U, Bulut C, Kınıkl S, Demiroz AP (2013). Extended Spectrum Beta-lactamases, AmpC and Metallo Beta-lactamases in Emerging Multi-drug Resistant Gram-negative Bacteria in Intensive Care Units.Open. Access. Scientific. Reports, 2:4. |
|
|
Amudhan SM, Sekar U, Arunagiri K, Sekar B (2011). OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii. Indian. J. Med. Microbiol. 29:269-274. |
|
|
Anoar KA, Ali FA, Omer SA (2014). Detection of Metallo B- lactamase enzyme in some Gram Negative Bacteria isolated from Burn Patients in Sulaimani City, Iraq. European. Sci. J. 10:3. ISSN: 1857 – 7881 (Print) e - ISSN 1857- 7431. |
|
|
Bhusal Y, Mihu CN, Tarrand JJ, Rolston KV (2011). Incidence of fluoroquinolone-resistant and extended-spectrum beta-lactamase producing Escherichia coli at a comprehensive cancer center in the United States. Chemother. 57:335-338. |
|
|
Black JA, Moland ES, Thomson KS (2005). Amp C disk test for detection of plasmid mediated Amp C β-lactamases. J. Clin. Microbiol. 43(7):3110- 3113. |
|
|
Carratala J, Gudiol F (2000). Changing epidemiology of bacterial infection in neutropenic patients with cancer. Antibiot. Chemother. 50:1-9. |
|
|
Chakraborty D, Basu S, Das S (2011). Study on some Gram negative multidrug resistant bacteria and their molecular characterization. Asian. J. Pharmaceut. and Clin. Res. 4(1):108-112. ISSN- 0974-2441. |
|
|
Chen CY, Tsay W, Tang JL, Tien HF, Chen YC, Chang SC, Hsueh, PR (2010). Epidemiology of bloodstream infections in patients with haematological malignancies with and without neutropenia. Epidemiol. Infect. 138:1044-1051. |
|
|
Chu YWM, Afzal-Shah ETS, Houang MFI, Palepou DJ, Lyon N, Woodford, Livermore DM (2001). IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob. Agents. Chemother. 45:710-714. |
|
|
Cornaglia G, Mazzariol A, Lauretti L, Rossolini GM, Fontana R (2000). Hospital outbreak of carbapenem-resistant Pseudomonas aeruginosa producingVIM-1, a novel transferable metallo- -lactamase. Clin. Infec. Dis. 31(5):1119-1125. |
|
|
Crawford J, Dale DC, Lyman GH (2004). Chemotherapy-induced neutropenia: risks, consequences, and new directions for its management. Cancer. 100: 228-37. |
|
|
Dallenne C, Da Costa A, Decre A, Favier C, Arlet G (2010). Development of a set of multiplex PCR assays for the detection of genes encoding important b-lactamases in Enterobacteriaceae. J. Antimicrob. Chemother. doi:10.1093/jac/dkp498. |
|
|
Deshpande P, Rodrigues C, Shetty A, Kapadia F, Hedge A, Soman, R (2010). New Delhi Metallo-beta lactamase (NDM-1) in Enterobacteriaceae: treatment options with carbapenems compromised. J. Assoc. Phys. 58:147-149. |
|
|
Ellington MJ, Kistler J, Livermore DM, Woodford N (2007). Multiplex PCR for rapid detection of genes encoding acquired metallo-b-lactamases. J. Antimicrob. Chemother. 59:321-322. |
|
|
Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JAH, Wingard JR (2011). Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 52:427-431. |
|
|
Goossens H MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) (2000). (Meropenem Yearly Susceptibility Test Information Collection) results from Europe: comparison of antibiotic susceptibilities between countries and centre types. J. Antimicrob. Chemother. 46:39-52. |
|
|
Gupta A, Singh M, Singh H, Kumar L, Sharma A, Bakhshi S, Raina V, Thulkar S (2010). Infections in acute myeloid leukemia: an analysis of 382 febrile episodes. Med. Oncol. 27:1037-1045. |
|
|
Itokazu G, Quinn JP, Bell-Dixon C, Kahan FM, Weinstein RA (1996). Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national post marketing surveillance program. Clin. Infect. Dis. 23:779-784. |
|
|
Kumar MS, Lakshmi V, Rajagopalan R (2006). Occurrence of extended spectrum β- lactamases among Enterobacteriaceae species isolated at a tertiary care institute. Indian. J. Med. Microbiol. 24(3): 208-11. |
|
|
Kumar V, Sen MR, Nigam C, GahlotKumari S (2012). Burden of different beta-lactamase classes among clinical isolates of AmpC-producing Pseudomonas aeruginosa in burn patients: A prospective study. Indian. J. Crit. Care. Med. 16:136-140. |
|
|
Manoharan A, Sugumar M, KumarA, Jose H, Mathai D,&ICMR-ESBL study group (2012). Phenotypic & molecular characterization of AmpC β-lactamases among Escherichia coli, Klebsiella spp. &Enterobacter spp. from five Indian Medical Centers. Indian. J. Med. Res. 135: 359-364. |
|
|
Mathur P, Kapil A, Das B, Dhawan B (2002). Prevalence of extended spectrum beta lactamase producing Gram negative bacteria in a tertiary care hospital. Indian. J. Med. Res. 115:153-157. |
|
|
Mishra SK, Acharya J, Kattel HP, Koirala J, Rijal BP, Pokhrel BM (2012). Metallo-beta-lactamase Producing Gram-negative Bacterial isolates. J. Nepal. Health. Res. Counc. 10(22):208-213. |
|
|
Moland ES, Kim S, Hong SG, Keneeth & Thomson (2008). Newer β - lactamases: Clinical & Laboratory Implication Part 1. Clin. Microbiol. Newslett. 30:71-78. |
|
|
Nørgaard M (2012). Risk of Infections in Adult Patients with Haematological Malignancies. The Open. Infect. Dis. J. 6(Suppl 1: M4):46-51. |
|
|
Noyal MJC, Menezes GA, Harish BN, Sujatha S, Parija SC (2009). Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria. Indian. J. Med. Res. 129:707-712. |
|
|
Pai H, Kang CI, Byeon JH, Lee KD, Park WB, Kim HB, Kim EC, Oh MD, Choe KW (2004). Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae. Antimicrob. Agents. Chemother. 48(10):3720-3728. |
|
|
Perez-Perez FJ, Hanson ND (2002). Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. J. Clin. Microbiol. 40:2153-2162. |
|
|
Philippon A, Arlet G, Jacoby GA (2002). Plasmid-determined Amp C type β-lactamases. Antimicrob. Agents. Chemother. 46:1-11. |
|
|
Taneja N, Rao P, Arora J, Dogra A (2008). Occurrence of ESBL & Amp-C b-lactamases & susceptibility to newer antimicrobial agents in complicated UTI. Indian. J. Med. Res. 127:85-88. |
|
|
Uma Karthika R, Srinivasa Rao R, Sahoo S, Shashikala P, Kanungo R, Jayachandran S, Prashanth K (2009). Phenotypic and genotypic assays for detecting the prevalence of metallo-beta-lactamases in clinical isolates of Acinetobacter baumannii from a South Indian tertiary care hospital. J. Med. Microbiol. 58:430-435. |
|
|
Upadhyay S, Sen MR, Bhattacharjee A (2010). Presence of different beta-lactamase classes among clinical isolates of Pseudomonas aeruginosa expressingAmpC beta-lactamase enzyme. J. Infect. Dev. Ctries. 4(4):239-242. |
|
|
Varaiya A, Kulkarni N, Kulkarni M, Bhalekar P, Dogra J (2008). Incidence of metallo beta lactamase producing Pseudomonas aeruginosa in ICU patients. Indian. J. Med. Res. 127:398-402. |
|
|
Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y (2002). Imipenem-EDTA disk method for differentiation of metallo-beta-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801. |
|
|
Zavasci, AC, Carvalhaes CG, Picao RC and Gales AC (2010). Multidrug resistant Pseudomonas aeruginosa and Acintobacter baumannii resistance mechanisms and implications for therapy. Expert. Rev. Anti. Infect. Ther. 8:71-93. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
